
Amphastar Pharmaceuticals: Disappointing Q4 Earnings Send Stock Down – Analyst Perspective
Amphastar Pharmaceuticals: Q4 Earnings Miss Consensus, Insights On Thursday, Amphastar Pharmaceuticals Inc. (AMPH) reported its fourth-quarter financial results, revealing an adjusted earnings per share (EPS) of 92 cents. This figure represents a slight year-over-year increase from 88 cents in the same quarter of the previous year. However, the reported EPS fell short of the consensus…